A Multicenter Phase II Trial with Irinotecan plus Oxaliplatin as First-Line Treatment for Inoperable/Metastatic Cancer of the Biliary Tract-Reference-Cited by-同舟云学术

A Multicenter Phase II Trial with Irinotecan plus Oxaliplatin as First-Line Treatment for Inoperable/Metastatic Cancer of the Biliary Tract

Published:2010 Issue:5-6 Volume:78 Page:356-360
ISSN:1423-0232
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Karachaliou Niki,Polyzos Aris,Kentepozidis Nikolaos,Kakolyris Stylianos,Ziras Nikolaos,Vardakis Nikolaos,Kalykaki Antonia,Milaki Georgia,Georgoulias Vassilis,Androulakis Nikolaos

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study;Journal of Clinical Oncology;2022-01-20

2. Radiologic Evaluation and Structured Reporting Form for Extrahepatic Bile Duct Cancer: 2019 Consensus Recommendations from the Korean Society of Abdominal Radiology;Korean Journal of Radiology;2021

3. Remarkable Response of Metastatic Gallbladder Carcinoma to Apatinib After Failed Multiline Chemotherapies: A Case Report and Literature Review;Frontiers in Oncology;2019-11-08

4. Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study;BMC Cancer;2019-10-23

5. Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study;Journal of Gastrointestinal Cancer;2016-10-06